Taro Divisions
Taro Corporate - Taro Pharmaceutical
Industries Ltd. - The gateway to all Taro sites. Learn about Taro's
pharmaceutical research, manufacturing and marketing capabilities, as well as
the company's products, locations, history and Nasdaq-traded shares. Plus, the
latest news on Taro.
Taro Israel - Taro Pharmaceutical
Industries Ltd. -
In Hebrew. Taro Israel performs basic research, conducts clinical trials,
synthesizes active pharmaceutical ingredients, manufactures finished
pharmaceutical products, and markets them to physicians, pharmacists and
consumers.
Taro USA - Taro Pharmaceuticals
U.S.A., Inc. - The U.S. is Taro's largest market, representing more
than 85% of the Company's sales. Includes a complete guide to Taro USA 's
prescription and over-the-counter products, both branded and generic.
Taro Canada - Taro Pharmaceuticals
Inc. -Taro entered
the North American marketplace with the establishment of Taro Canada in 1984.
Today, Taro Canada is a major Taro research center and a leading manufacturer
and exporter of topical products used in dermatology. Includes a complete
product guide.
Taro Pharmaceuticals (UK)
Ltd. - sales
operations offer a growing line of affordable, high-quality prescription
products.
Taro International -
Taro International provides active pharmaceutical ingredients (APIs) and
finished pharmaceutical products in a variety of forms.
TaroPharma USA -
Offers US Pediatricians and Dermatologists proprietary product lines for a
variety of patient needs.
TaroPharma Canada -
Formerly known as OptimaPharma, TaroPharma Canada offers proprietary
prescription and over-the-counter products used in dermatology.
Taro Corporate Investor Relations:
Taro.com - Includes a wide
range of stock information, news, annual reports, quarterly earnings
announcements, and more.
Taro Sites for Consumers and Professionals:
Ovide® (malathion) Lotion
0.5%
LUSTRA-ULTRA™ (hydroquinone USP
4%), LUSTRA-AF ® (hydroquinone USP 4%), and LUSTRA ® (hydroquinone USP
4%)
U-Kera E™ Urea Emollient Cream, 40%
For US
Dermatologists - Taropharmadermatology is ready to serve dermatologists
and their patients with information about Taropharma‘s wide range of topical Rx
and OTC products.
For US Pediatricians
-Taropharmapeds is ready to serve pediatricians, children (and
their parents!).
Warfarin USA -
Tarowarfarin.com - Information to assist US residents interested in
learning about warfarin sodium therapy.
Warfarin Information for
Doctors - Tarowarfarinpro.com - Useful information for doctors in the
U.S. to share with their patients about warfarin sodium therapy.
Warfarin Canada
Tarowarfarin.ca - Information to assist Canadian residents interested
in learning about warfarin sodium therapy.
Canada Warfain Information
for Doctors - Tarowarfarinpro.ca - Useful information for doctors in
Canada to share with their patients about warfarin sodium therapy.
RxDesktop - On-line
resource for pharmacists featuring conversion tools such as dosage calculators,
prescription abbreviations, weights and measures.
Rokamol (in Hebrew)
Nikita (in Hebrew)
|
IMPORTANT SAFETY INFORMATION
U-Kera E is indicated for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar.
Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged nails, ingrown nails and devitalized nails.
U-Kera E is contraindicated in patients with known hypersensitivity to any of the listed ingredients. Local adverse reactions that may occur and normally disappear on discontinuing use include transient stinging, burning, itching and irritation. If redness or irritation occurs, discontinue use. Contact with eyes, lips or mucous membranes should be avoided. See full .
|
|
|
 |
® 2000-2007 All Rights Reserved
|
The U-Kera E and TaroPharma logos are trademarks of
Taro Pharmaceuticals U.S.A., Inc.
|
|
|